Median Technologies announced on Monday that it would be changing the name of iBiopsy, its portfolio of medical device software based on AI and machine learning technologies, which will be renamed 'eyonis'.

The imaging services specialist adds that the adoption of this new name will be accompanied by the introduction of a new logo and tagline.

This new brand combines the English word for 'eye' to refer to the visual aspect of imaging, backing it up with 'onis', which evokes the power and efficiency of medical imaging.

The visual identity of the eyonis brand was unveiled yesterday at the opening of the annual conference of the North American Society of Radiology (RSNA), held in Chicago.

Median's teams plan to present the latest advances in eyonis, which will become both the marketing name for Median's medical device software portfolio in the US and Europe, once FDA 510K clearance has been obtained and CE marking in Europe.

Listed on the Paris Bourse, Median Technologies shares were up 2% on Monday following these announcements.

Copyright (c) 2023 CercleFinance.com. All rights reserved.